Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Reimbursement News › CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD

CareDx AlloSure Kidney, Heart Tests Garner Palmetto Draft LCD

Aug 22, 2019
|
staff reporter

NEW YORK – Medicare contractor Palmetto GBA has issued a draft local coverage determination for two indications of CareDx's AlloSure, a non-invasive blood test that measures transplant injury via donor-derived cell-free DNA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
18
Featured Webinar

COVID-19 Wastewater-Based Epidemiology: Methods and Insights for SARS-CoV-2 Community Surveillance

As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. Laboratory, Provider Organizations Urge HHS to Update COVID-19 Testing Prioritization Guidelines

  2. Sherlock Bio, Dartmouth-Hitchcock Health Partner on Clinical Study of Sherlock CRISPR SARS-CoV-2 Kit

  3. Solaris Diagnostics, Alpha Genomix Coronavirus Tests Get FDA Emergency Use Authorization

  4. T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates

  5. HTG Molecular Q2 Revenues Drop 66 Percent as COVID-19 Forces Global Facility Closures

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.